News on this topic
/cloudfront-us-east-2.images.arcpublishing.com/reuters/C7EEJAUTFRO5LJS74NX44RTBDM.jpg)
Amgen taking different path to weight loss windfall: The popularity of a new generation of weight-loss medicines is inspiring a growing number of drugmakers to ...
reuters.com/business/healthcare-pharmaceuticals/amgen-taking-different-path-weight-loss-windfall-2024-02-06/
Similar to This
Previous

Paid articlePaywall Beyond statins, one drug lowered heart attack risk by 20%: A new study could help doctors figure out what medicine to prescribe for cholesterol when statins ...
statnews.com/2026/11/05/repatha-vs-zetia-cholesterol-study-heart-attack-risk/

Paid articlePaywall Amgen’s Repatha linked to fewer heart attacks: Today's biotech news includes Novartis citing more tumor reports, PhRMA's big spending on search ads ...
statnews.com/2026/11/06/biotech-news-amgen-repatha-linked-to-fewer-heart-attacks/

California drugmaker Amgen reports theft of patient data in cyber incident: Amgen Inc. experienced a cyber incident that involved the theft of patient ...
mercurynews.com/2026/08/03/amgen-reports-theft-of-patient-data-in-cyber-incident/

Colorado can’t cap price of arthritis drug Enbrel, federal judge rules: Colorado can’t cap the price of arthritis medication Enbrel while a lawsuit challenging ...
denverpost.com/2026/07/07/colorado-prescription-drug-affordability-board-enbrel/

Amgen's rare disease drug linked to deaths, liver injuries in Japan, Kissei reports
reuters.com/business/healthcare-pharmaceuticals/amgens-rare-disease-drug-linked-deaths-liver-injuries-japan-wsj-reports-2026-05-15/

Amgen Surges On Broad-Based Beat As Investors Zone In On Obesity: Amgen stock popped Wednesday on a solid third-quarter beat as investors focus on what's next ...
investors.com/news/technology/amgen-stock-amgen-earnings-q3-2025/

Amgen experimental weight-loss drug needs lower dose to limit side effects: Amgen's long-acting experimental obesity drug MariTide needs to be given at a low ...
reuters.com/business/healthcare-pharmaceuticals/low-start-dose-amgen-experimental-weight-loss-drug-limits-side-effects-2025-06-23/

New Obesity Drug MariTide Helps Patients Lose Up to 20% of Weight, Early Data Shows
nytimes.com/2024/11/26/health/weight-loss-drug-maritide-amgen.html

Amgen Inc. (AMGN) Wells Fargo 2024 Healthcare Conference (Transcript): Amgen Inc. (NASDAQ:AMGN) Wells Fargo 2024 Healthcare Conference Call September 5 ...
seekingalpha.com/article/4719330-amgen-inc-amgn-wells-fargo-2024-healthcare-conference-transcript
Obesity, Cardiovascular Disease, and Prediabetes: Do you know which anti-obesity pharmacotherapy is most effective for your patients with obesity?
medscape.org/viewarticle/1001462
/cloudfront-us-east-1.images.arcpublishing.com/morningstar/T5MECJUE65CADONYJ7GARN2A3E.jpeg)
Obesity Drug Stocks: Where to Invest Now: Eli Lilly and Novo Nordisk have staged big rallies. Here’s how investors can approach this potentially huge opportunity ...
morningstar.com/stocks/obesity-drug-stocks-where-invest-now

Colorado Is Trying to Cap a Drug’s Price. Big Pharma Has Other Plans: After a state board declared Enbrel “unaffordable,” some lawmakers want to exempt large ...
rollingstone.com/politics/politics-features/colorado-drug-price-enbrel-pharma-1234977554/
Amgen quarterly profit rises 15%, obesity drug trials are on track: Amgen on Tuesday said its adjusted fourth-quarter profit rose 15%, driven by a 20% increase ...
reut.rs/3HRMKJ4
/cloudfront-us-east-2.images.arcpublishing.com/reuters/GIB2O5BICRLWPONDNIAMZ5NXVU.jpg)
Drugmakers plot way into obesity market with deals and development: Pharmaceutical executives from Amgen to Pfizer are plotting to break into the lucrative ...
reut.rs/42afvKF
Paid articlePaywall Amgen to lay off 350 employees at Irish-based Horizon Technologies: Biotechnology company announces cuts following deal to acquire Horizon
businesspost.ie/tech/amgem-to-lay-off-350-employees-at-irish-based-horizon-technologies/
/cloudfront-us-east-2.images.arcpublishing.com/reuters/MT7PDJU2XVPHBHYPVJRMMJ2G3Y.jpg)
Analysis: FTC settlement could shelter Amgen from US price cuts, taxes: The U.S. Federal Trade Commission's decision on Friday to allow Amgen's takeover of ...
reuters.com/business/healthcare-pharmaceuticals/ftc-settlement-could-shelter-amgen-us-price-cuts-taxes-2023-09-05/
Paid articlePaywall U.S. FTC allows Amgen to go ahead with US$27.8-billion Horizon deal: The FTC filed a lawsuit on May 16 in a rare move to block a large pharmaceutical deal ...
theglobeandmail.com/business/international-business/article-us-ftc-allows-amgen-to-go-ahead-with-us278-billion-horizon-deal/

California, other states join FTC bid to block Amgen deal: The states of California, New York, Illinois, Minnesota, Washington and Wisconsin have joined a ...
reuters.com/markets/deals/california-other-states-join-ftc-bid-block-amgen-deal-2023-06-22/

US FTC sues to block Amgen's $27.8 bln deal for Horizon Therapeutics: The U.S. Federal Trade Commission said on Tuesday it has filed a lawsuit to stop Amgen ...
reuters.com/markets/deals/ftc-sues-block-amgens-278-bln-deal-horizon-therapeutics-statement-2023-05-16/

Amgen sues Sandoz to block generic version of bone cancer and osteoporosis drugs: Reportedly, Novartis which is also named in this complaint is preparing to spin ...
financialexpress.com/healthcare/pharma-healthcare/amgen-sues-sandoz-to-block-generic-version-of-bone-cancer-and-osteoporosis-drugs/3072497/
Next
